Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Multiple Endocrine Neoplasia

Known as: Endocrine Adenomatosis, Familial, Multiple Endocrine Adenomatoses, Multiple Endocrine Adenopathies 
An autosomal dominant inherited neoplastic syndrome characterized by the development of various endocrine neoplasms and abnormalities in various… Expand
National Institutes of Health

Related topics

Related topics

24 relations
ApudomaBlood supply aspectsEndocrine systemEpithelial Cells
Expand

Broader (2)

Endocrine Gland NeoplasmsHereditary Diseases

Narrower (3)

Multiple Endocrine Neoplasia Type 2aMultiple Endocrine Neoplasia Type 2bMultiple Endocrine Neoplasia, Type IV

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
BACKGROUND Selinexor, a selective inhibitor of nuclear export compound that blocks exportin 1 (XPO1) and forces nuclear… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Review
2019
Review
2019
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
BACKGROUND As lenalidomide becomes increasingly established for upfront treatment of multiple myeloma, patients refractory to… Expand
Is this relevant?
Review
2019
Review
2019
Impact of sex hormones on immune function and multiple sclerosis development
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) affecting young people and leading… Expand
Is this relevant?
Review
2019
Review
2019
The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis
Neuroinflammation is the coordinated response of the central nervous system (CNS) to threats to its integrity posed by a variety… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2019
Review
2019
Occurrence, control and fate of contaminants of emerging concern in environmental compartments in Brazil.
This is the first review to present data obtained in Brazil over the years regarding contaminants of emerging concern (CEC) and… Expand
Is this relevant?
Review
2018
Review
2018
Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Spinal cord atrophy (SCA) is an important emerging outcome measure in multiple sclerosis (MS); however, there is limited… Expand
Is this relevant?
Review
2018
Review
2018
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
PURPOSE To develop guidelines for the work-up and radiation therapy (RT) management of patients with plasma cell neoplasms… Expand
Is this relevant?
Review
2018
Review
2018
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR… Expand
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Review
2018
Review
2018
Integrated Aedes management for the control of Aedes-borne diseases
Background Diseases caused by Aedes-borne viruses, such as dengue, Zika, chikungunya, and yellow fever, are emerging and… Expand
  • figure 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Review
2018
Review
2018
The 2017 WHO classification of pituitary adenoma: overview and comments
The fourth edition of the World Health Organization classification of endocrine tumors has been recently published. There are two… Expand
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE